NHS GLOBAL HOLDINGS LLC – Trademark Portfolio
Entity Type: 16
NHS GLOBAL HOLDINGS LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 4 are pending. Notable registered marks include VK2, SEA OF GREENS, PROSTATE MIRACLE, and PROSTATE MIRACLE ADVANCED FORMULA. The owner is based in SHERIDAN, WY.
1309 COFFEEN AVENUE STE 1200
SHERIDAN, WY 82801
Showing of trademarks Trademarks
Trademark Classifications
NHS GLOBAL HOLDINGS LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does NHS GLOBAL HOLDINGS LLC have?
NHS GLOBAL HOLDINGS LLC has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 pending.
What trademark classes does NHS GLOBAL HOLDINGS LLC file in?
NHS GLOBAL HOLDINGS LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NHS GLOBAL HOLDINGS LLC's most well-known trademarks?
NHS GLOBAL HOLDINGS LLC's registered trademark portfolio includes well-known marks such as VK2, SEA OF GREENS, PROSTATE MIRACLE, and PROSTATE MIRACLE ADVANCED FORMULA. These are among 4 currently registered trademarks in the portfolio.
What is NHS GLOBAL HOLDINGS LLC's trademark registration success rate?
NHS GLOBAL HOLDINGS LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 4 applications are pending review.